Indication
ANCA-associated vasculitis
1 clinical trial
1 product
Clinical trial
An Exploartory Trial of IMPT-514, An Autologous Anti-CD19/20 CAR T Therapy in Participants With Active, Refractory Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory MyopathyStatus: Not yet recruiting, Estimated PCD: 2025-05-31
Product
IMPT-514